Suven Life Sciences Ltd. - Research Center
530239 SUVEN Group (B) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Sales | 11.84 | 13.48 | 14.41 | 285.67 | 625.26 |
| Operating profit | -36.64 | -30.55 | -35.26 | 48.70 | 232.92 |
| Interest | 0.53 | 0.82 | 0.54 | 1.90 | 4.61 |
| Gross profit | -31.86 | -23.61 | -21.77 | 74.04 | 251.58 |
| EPS (Rs) | -2.49 | -1.78 | -1.08 | 3.08 | 12.45 |
Annual
results in details
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Other income | 5.32 | 7.75 | 14.04 | 27.25 | 23.27 |
| Stock adjustment | - | - | - | -9.29 | -21.20 |
| Raw material | - | - | - | 79.62 | 174.90 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 17.46 | 15.29 | 14.60 | 33.85 | 58.74 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | 25.17 | 25.94 | 59.37 | 58.47 |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 31.02 | 3.57 | 9.14 | 73.43 | 121.44 |
| Provisions made | - | - | - | - | - |
| Depreciation | 4.39 | 4.35 | 4.17 | 10.79 | 21.31 |
| Taxation | - | -5.32 | -12.18 | 24.06 | 71.84 |
| Net profit / loss | -36.25 | -22.63 | -13.75 | 39.19 | 158.43 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 14.54 | 12.73 | 12.73 | 12.73 | 12.73 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -309.37 | -226.64 | -244.63 | 17.05 | 37.25 |
| GPM (%) | -185.62 | -111.19 | -76.51 | 23.66 | 38.79 |
| NPM (%) | -211.22 | -106.59 | -48.34 | 12.53 | 24.43 |
Mutual Fund Selector
Find the fund that is right for you
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis